Dual-Temporal Resolution Dynamic Contrast-Enhanced MRI Protocol for Blood-Brain Barrier Permeability Measurement in Enhancing Multiple Sclerosis Lesions

被引:35
作者
Jelescu, I. O. [1 ]
Leppert, I. R. [1 ]
Narayanan, S. [1 ]
Araujo, D. [1 ,2 ]
Arnold, D. L. [1 ]
Pike, G. B. [1 ]
机构
[1] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada
[2] Univ Sao Paulo, Hosp Clin Ribeirao Preto, Sao Paulo, Brazil
基金
加拿大健康研究院;
关键词
blood-brain barrier; DCE-MRI; multiple sclerosis; ARTERIAL INPUT FUNCTION; KINETIC-PARAMETERS; GLATIRAMER ACETATE; T-1-WEIGHTED MRI; GADOLINIUM-DTPA; MS; TRACER; VOLUME; LEAKAGE; MODEL;
D O I
10.1002/jmri.22565
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To design a more accurate and reproducible technique for the measurement of blood-brain barrier (BBB) permeability in gadolinium-enhancing multiple sclerosis (MS) lesions. Materials and Methods: Four MS patients were scanned using a new dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) protocol based on an uninterrupted two-part acquisition consisting of an initial part at high temporal and low spatial resolutions and a second part at low temporal and high spatial resolutions. The method preserves both the high spatial resolution needed for the often small size of lesions and the high temporal resolution required during the first minute after injection to sufficiently sample the first-pass bolus. Simulations compared the performance of this new protocol with the conventional one at low temporal and high spatial resolutions throughout. Results: The BBB permeability estimates changed by up to 33% between the two protocols. The new protocol led to simulated error on K-trans of 7%-10%, versus 7%-30% with the conventional protocol, and was more robust with respect to offsets between acquisition and injection start times, differences in shape of the first-pass peak, and permeability values. Conclusion: The dual-temporal resolution protocol produces improved BBB permeability estimates and provides a more complete view of active inflammatory MS lesion pathology.
引用
收藏
页码:1291 / 1300
页数:10
相关论文
共 31 条
[1]   MRI in the diagnosis and management of multiple sclerosis [J].
Arnold, DL ;
Matthews, PM .
NEUROLOGY, 2002, 58 (08) :S23-S31
[2]   Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials [J].
Barkhof, F ;
Held, U ;
Simon, JH ;
Daumer, M ;
Fazekas, F ;
Filippi, M ;
Frank, JA ;
Kappos, L ;
Li, D ;
Menzler, S ;
Miller, DH ;
Petkau, J ;
Wolinsky, J .
NEUROLOGY, 2005, 65 (09) :1447-1454
[3]   Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study [J].
Cadavid, D. ;
Wolansky, L. J. ;
Skurnick, J. ;
Lincoln, J. ;
Cheriyan, J. ;
Szczepanowski, K. ;
Kamin, S. S. ;
Pachner, A. R. ;
Halper, J. ;
Cook, S. D. .
NEUROLOGY, 2009, 72 (23) :1976-1983
[4]   Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state [J].
Deoni, SCL ;
Rutt, BK ;
Peters, TM .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :515-526
[5]   Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS [J].
Filippi, M ;
Yousry, T ;
Campi, A ;
Kandziora, C ;
Colombo, B ;
Voltz, R ;
Martinelli, V ;
Spuler, S ;
Bressi, S ;
Scotti, G ;
Comi, G .
NEUROLOGY, 1996, 46 (02) :379-384
[6]   MRI techniques to monitor MS evolution - The present and the future [J].
Filippi, M ;
Grossman, RI .
NEUROLOGY, 2002, 58 (08) :1147-1153
[7]   A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas [J].
Haroon, HA ;
Buckley, DL ;
Patankar, TA ;
Dow, GR ;
Rutherford, SA ;
Balériaux, D ;
Jackson, A .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 19 (05) :527-536
[8]   Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging [J].
Horsfield, MA ;
Morgan, B .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 20 (04) :723-729
[9]  
JELESCU IO, 2010, JOINT SCI M ISMRM ES
[10]   QUANTITATION OF BLOOD-BRAIN-BARRIER DEFECT BY MAGNETIC-RESONANCE-IMAGING AND GADOLINIUM-DTPA IN PATIENTS WITH MULTIPLE-SCLEROSIS AND BRAIN-TUMORS [J].
LARSSON, HBW ;
STUBGAARD, M ;
FREDERIKSEN, JL ;
JENSEN, M ;
HENRIKSEN, O ;
PAULSON, OB .
MAGNETIC RESONANCE IN MEDICINE, 1990, 16 (01) :117-131